반응식
Cl.Cl.Cl.S1C(C2C=CN=C([NH:15][CH2:16][CH2:17][CH2:18][N:19]3[CH2:24][CH2:23][N:22]([CH3:25])[CH2:21][CH2:20]3)N=2)=CC2C=CC=CC1=2.Cl[C:31]1[N:36]=[C:35]([C:37]2[S:41][C:40]3[CH:42]=[CH:43][CH:44]=[C:45]([OH:46])[C:39]=3[CH:38]=2)[C:34]([CH3:47])=[CH:33][N:32]=1.NCCCN1CCN(C)CC1>>[CH3:47][C:34]1[C:35]([C:37]2[S:41][C:40]3[CH:42]=[CH:43][CH:44]=[C:45]([OH:46])[C:39]=3[CH:38]=2)=[N:36][C:31]([NH:15][CH2:16][CH2:17][CH2:18][N:19]2[CH2:20][CH2:21][N:22]([CH3:25])[CH2:23][CH2:24]2)=[N:32][CH:33]=1참가 물질
4
반응물 3
생성물 1
실험 절차
Using the method of [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-[3-(4-methylpiperazin-1-yl)-propyl]-amine tri-hydrochloride, the title compound is prepared from 2-(2-chloro-5-methylpyrimidin-4-yl)benzo[b]thiophen-4-ol and 1-(3-aminopropyl)-4-methylpiperazine and isolated as a solid. ES+(m/z) 398 [M+H].
후처리
- customisolated as a solid
출처 및 근거
- ORD 기록
- ord-a9dfc7bd51974ca6ae67844a58dcff0b
- 출처 데이터셋
- uspto-grants-2009_06
- 특허 번호
- US07547691B2
연결된 노트
불러오는 중…